Select Eye Care

Compiled by PlainTrial · August 8, 2026

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Select Eye Care sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Select Eye Care: 1 sponsored US clinical trial, 1 recruiting.

Select Eye Care sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Primary Open Angle Glaucoma (POAG), with 1 trials.

Select Eye Care is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma

NCT07147647

Therapeutic Areas

Primary Open Angle Glaucoma (POAG) 1

What is open in the Select Eye Care pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Primary Open Angle Glaucoma (POAG) (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Select Eye Care: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Select Eye Care sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Select Eye Care sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

1200 Pharma · 2 trials · 50% recruiting
1ST Biotherapeutics · 2 trials · 50% recruiting
3 Waves Wellness · 2 trials · 0% recruiting
3EO Health · 2 trials · 0% recruiting

Sponsors near 100% open enrollment (± trial volume)

AAVantgarde Bio Srl · 100% recruiting · 2 trials
Acorn Biolabs · 100% recruiting · 3 trials
Acrivon Therapeutics · 100% recruiting · 2 trials
ADARx Pharmaceuticals · 100% recruiting · 4 trials

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Select Eye Care page

1 registered trials is a research-attention snapshot, not an endorsement of Select Eye Care or any single study.

1 of Select Eye Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
Primary Open Angle Glaucoma (POAG) is the condition Select Eye Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Primary Open Angle Glaucoma (POAG) trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Select Eye Care pipeline card: 1 registered trials from official public datasets.Report a data error.